These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 36524692)

  • 21. Spectral-Domain OCT-Based Prevalence and Progression of Macular Atrophy in the HARBOR Study for Neovascular Age-Related Macular Degeneration.
    Gune S; Abdelfattah NS; Karamat A; Balasubramanian S; Marion KM; Morgenthien E; Sadda SR
    Ophthalmology; 2020 Apr; 127(4):523-532. PubMed ID: 31718842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical experience of switching anti-VEGF therapy from ranibizumab to aflibercept in age-related choroidal neovascularization.
    Van Lancker L; Petrarca R; Moutsouris K; Masaoutis P; Kampougeris G
    Eur J Ophthalmol; 2017 May; 27(3):342-345. PubMed ID: 27739561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term full-field and multifocal electroretinographic changes after treatment with ranibizumab in patients with diabetic macular edema.
    Yigit K; Inan ÜÜ; Inan S; Dogan M; Yavas GF; Cetinkaya E
    Int Ophthalmol; 2021 Apr; 41(4):1487-1501. PubMed ID: 33486648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Using optical coherence tomography angiography in assessment of the anti-vascular endothelial growth factor effect for pathological vascular tissue in age-related macular degeneration and polypoidal choroidal vasculopathy.
    Shen YS; Cheng CK
    Eur J Ophthalmol; 2021 May; 31(3):1267-1280. PubMed ID: 32228025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ranibizumab for choroidal neovascularization associated with adult-onset foveomacular vitelliform dystrophy: one-year results.
    Mimoun G; Caillaux V; Querques G; Rothschild PR; Puche N; Souied EH
    Retina; 2013 Mar; 33(3):513-21. PubMed ID: 23400081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. INCIDENCE AND LONG-TERM VISUAL ACUITY OUTCOMES OF RETINAL PIGMENT EPITHELIUM TEARS AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
    Vazquez-Alfageme C; Nicholson L; Hamilton RD; Patel PJ
    Retina; 2019 Apr; 39(4):664-669. PubMed ID: 29324593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Five-year treatment outcomes following intravitreal ranibizumab injections for neovascular age-related macular degeneration in Japanese patients.
    Wada I; Oshima Y; Shiose S; Kano K; Nakao S; Kaizu Y; Yoshida S; Ishibashi T; Sonoda KH
    Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1411-1418. PubMed ID: 31119425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of Time to Retreatment and Visual Function Between Ranibizumab and Aflibercept in Age-Related Macular Degeneration.
    Inoue M; Yamane S; Sato S; Sakamaki K; Arakawa A; Kadonosono K
    Am J Ophthalmol; 2016 Sep; 169():95-103. PubMed ID: 27320059
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of intravitreal aflibercept and ranibizumab injections on subfoveal and peripapillary choroidal thickness in eyes with neovascular age-related macular degeneration.
    Yun C; Oh J; Ahn J; Hwang SY; Lee B; Kim SW; Huh K
    Graefes Arch Clin Exp Ophthalmol; 2016 Sep; 254(9):1693-702. PubMed ID: 26781585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. INTRAVITREAL AFLIBERCEPT FOR CHOROIDAL NEOVASCULARIZATION DUE TO AGE-RELATED MACULAR DEGENERATION UNRESPONSIVE TO RANIBIZUMAB THERAPY.
    Sarao V; Parravano M; Veritti D; Arias L; Varano M; Lanzetta P
    Retina; 2016 Apr; 36(4):770-7. PubMed ID: 26398691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Macular neovascularization lesion type and vision outcomes in neovascular age-related macular degeneration: post hoc analysis of HARBOR.
    Freund KB; Staurenghi G; Jung JJ; Zweifel SA; Cozzi M; Hill L; Blotner S; Tsuboi M; Gune S
    Graefes Arch Clin Exp Ophthalmol; 2022 Aug; 260(8):2437-2447. PubMed ID: 35239009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined fluorescein angiography and spectral-domain optical coherence tomography imaging of classic choroidal neovascularization secondary to age-related macular degeneration before and after intravitreal ranibizumab injections.
    Coscas F; Querques G; Forte R; Terrada C; Coscas G; Souied EH
    Retina; 2012 Jun; 32(6):1069-76. PubMed ID: 22466476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ranibizumab treatment for choroidal neovascularization secondary to causes other than age-related macular degeneration with good baseline visual acuity.
    Erol MK; Ozdemir O; Coban DT; Ceran BB; Bulut M
    Semin Ophthalmol; 2014 Mar; 29(2):108-13. PubMed ID: 24409939
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in cone-driven functions after intravitreal aflibercept injections in patients with age-related macular degeneration.
    Nishimura T; Machida S; Hara Y
    Doc Ophthalmol; 2020 Oct; 141(2):137-147. PubMed ID: 32100141
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aflibercept for neovascular age-related macular degeneration.
    Sarwar S; Clearfield E; Soliman MK; Sadiq MA; Baldwin AJ; Hanout M; Agarwal A; Sepah YJ; Do DV; Nguyen QD
    Cochrane Database Syst Rev; 2016 Feb; 2(2):CD011346. PubMed ID: 26857947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ranibizumab for vascularized pigment epithelial detachment: 1-year anatomic and functional results.
    Chevreaud O; Oubraham H; Cohen SY; Jung C; Blanco-Garavito R; Gherdaoui F; Souied EH
    Graefes Arch Clin Exp Ophthalmol; 2017 Apr; 255(4):743-751. PubMed ID: 27913869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of indocyanine green angiography imaging in further differential diagnosis of patients with nAMD who are morphologically poor responders to ranibizumab in a real-life setting.
    Ozkaya A; Alagoz C; Garip R; Alkin Z; Perente I; Yazici AT; Taskapili M
    Eye (Lond); 2016 Jul; 30(7):958-65. PubMed ID: 27080484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peripapillary choroidal thickness after intravitreal ranibizumab injections in eyes with neovascular age-related macular degeneration.
    Yun C; Oh J; Choi KE; Hwang SY; Kim SW; Huh K
    BMC Ophthalmol; 2016 Mar; 16():25. PubMed ID: 26951107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variable response of vascularized pigment epithelial detachments to ranibizumab based on lesion subtypes, including polypoidal choroidal vasculopathy.
    Inoue M; Arakawa A; Yamane S; Kadonosono K
    Retina; 2013 May; 33(5):990-7. PubMed ID: 23446653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of structural and functional outcome of aflibercept versus ranibizumab in patients with myopic choroidal neovascularization.
    Howaidy A; Eldaly ZH
    Eur J Ophthalmol; 2021 Jan; 31(1):211-217. PubMed ID: 31690105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.